Silencing circANKRD36 protects H9c2 cells against lipopolysaccharide-induced injury via up-regulating miR-138.
Myocarditis refers to the inflammatory process that affects the muscle tissue of the heart. Persistent myocardial inflammation promotes myocardial cell damage, which ultimately leads to heart failure or death. Therefore, we aimed to explore the functional impacts of circANKRD36 on myocarditis. H9c2 cells were pre-treated with lipopolysaccharide (LPS). Viability and apoptosis were evaluated utilizing CCK-8 assay and flow cytometry. Inflammatory cytokines mRNA expression and production were assessed by qRT-PCR and ELISA. Western blot was utilized to distinguish apoptosis and inflammatory related factors expression. Sequentially, the above mentioned parameters were reassessed when overexpressed miR-138. LPS declined viability and as well as raised apoptosis and inflammatory injury in H9c2 cells. Silencing circular RNA ANKRD36 (si-circANKRD36) alleviated apoptosis and inflammatory injury induced by LPS. MiR-138 expression was suppressed by LPS and elevated by si-circANKRD36. Increase of viability and inflammatory injury induced by si-circANKRD36 was alleviated by down-regulation of miR-138. Eventually, si-circANKRD36 inhibited p38MAPK/NF-κB pathway which activated by LPS via up-regulating miR-138. Si-circANKRD36 exerted its anti-apoptosis and anti-inflammatory function under the condition of LPS in H9c2 cells through p38MAPK/NF-κB pathway and up-regulation of miR-138.